Cambodia vs Comoros: Access to anti-retroviral drugs, male
Cambodia
96.0%
in 2024
Comoros
98.0%
in 2024
Cambodia rank
3rd
Comoros rank
1st
Access to anti-retroviral drugs, male over time
- Cambodia
- Comoros
How they compare
Comoros currently reports 98.0% against 96.0% in Cambodia, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Comoros ahead.
Cambodia ranks 3rd and Comoros ranks 1st of 141 countries.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Comoros | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.4% | 0.0% | 16.4% | Cambodia |
| 2010s | 62.4% | 26.4% | 36.0% | Cambodia |
| 2020s | 86.6% | 67.4% | 19.2% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cambodia or Comoros?
- Comoros, at 98.0% against 96.0% in Cambodia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cambodia and Comoros?
- 2.0%, with Comoros ahead.
- How many years of comparable data are there for Cambodia and Comoros?
- 25 years are reported by both, from 2000 to 2024.
- How do Cambodia and Comoros rank globally for access to anti-retroviral drugs, male?
- Cambodia ranks 3rd and Comoros ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.